SCHEMBL23065084

SCHEMBL23065084

O=c1c2cccc(Cl)c2nc(Nc2ccccc2)n1-c1cccnc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.49
PIK3R1 P27986 1/20 0.49
PIK3CA P42336 1/20 0.49
PIK3CB P42338 1/20 0.49
PIK3CG P48736 1/20 0.49
ALOX12 P18054 1/20 0.48
PDE7A Q13946 1/20 0.47
MDM2 Q00987 1/20 0.44
WEE1 P30291 1/20 0.43
RAB9A P51151 2/20 0.42
PIM1 P11309 3/20 0.41
PIM2 Q9P1W9 3/20 0.41
MAPT P10636 4/20 0.40
MAT2A P31153 1/20 0.40
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
PSD A5PKW4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958349 0.93 PDE7A (0.47) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG
SCHEMBL23065107 0.90 PDE7A (0.56) PIK3CDPIK3CGPDE7AWEE1RAB9A
SCHEMBL24090125 0.82 PIK3CD (0.50) PIK3CDPIK3R1PIK3CAPIK3CBPIK3CG
SCHEMBL23958201 0.80 ALOX12 (0.43) ALOX12PDE7AMDM2MAPTPSD
SCHEMBL29623145 0.80 ALDH1A1 (0.48) ALOX12MDM2RAB9AMAT2A
SCHEMBL24089900 0.80 ALDH1A1 (0.48) ALOX12MDM2RAB9AMAT2A
SCHEMBL23958356 0.80 ALOX12 (0.48) ALOX12PDE7AMDM2RAB9APIM1
SCHEMBL23065144 0.79 PDE7A (0.52) PIK3CDPIK3CGPDE7ARAB9APIM1
SCHEMBL23958352 0.78 G6PD (0.44) ALOX12MDM2RAB9AMAPTNPC1
SCHEMBL24110995 0.76 ALOX12 (0.57) ALOX12PDE7AMDM2RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352366-B2 2-aminoquinazolinone derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-06-07 US disclosed
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-05-12 US disclosed
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-09 US disclosed
WO-2021039968-A1 2-AMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 2021-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, CRKL PIK3CD 4554/4885PIK3R1 3904/4885PIK3CA 4389/4885
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, SLC26A3 PIK3CD 4497/4885PIK3R1 4054/4885PIK3CA 4289/4885
US-11352366-B2 2-aminoquinazolinone derivative CNKSR1, HAX1, SLC26A3 PIK3CD 4497/4885PIK3R1 4054/4885PIK3CA 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.